Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 2021; Volume 99,Issue 5

Special Section on Phosphoproteomic Analysis of G Protein-Coupled Pathways - Axelrod Symposium

  • Phosphoproteomic Analysis as an Approach for Understanding Molecular Mechanisms of cAMP-Dependent Actions
    You have access
    Phosphoproteomic Analysis as an Approach for Understanding Molecular Mechanisms of cAMP-Dependent Actions
    Joseph A. Beavo, Martin Golkowski, Masami Shimizu-Albergine, Michael-Claude Beltejar, Karin E. Bornfeldt and Shao-En Ong
    Molecular Pharmacology May 2021, 99 (5) 342-357; DOI: https://doi.org/10.1124/molpharm.120.000197
  • You have access
    Phosphoproteomic Identification of Vasopressin/cAMP/Protein Kinase A–Dependent Signaling in Kidney
    Karim Salhadar, Allanah Matthews, Viswanathan Raghuram, Kavee Limbutara, Chin-Rang Yang, Arnab Datta, Chung-Lin Chou and Mark A. Knepper
    Molecular Pharmacology May 2021, 99 (5) 358-369; DOI: https://doi.org/10.1124/mol.120.119602
  • Open Access
    Phosphoproteomics-Based Characterization of Prostaglandin E2 Signaling in T Cells
    Anna Mari Lone and Kjetil Taskén
    Molecular Pharmacology May 2021, 99 (5) 370-382; DOI: https://doi.org/10.1124/molpharm.120.000170
  • Axelrod Symposium 2019: Phosphoproteomic Analysis of G-Protein–Coupled Pathways
    You have access
    Axelrod Symposium 2019: Phosphoproteomic Analysis of G-Protein–Coupled Pathways
    Katharina Schleicher and Manuela Zaccolo
    Molecular Pharmacology May 2021, 99 (5) 383-391; DOI: https://doi.org/10.1124/mol.119.118869
  • You have access
    Proteomic Approaches to Investigate Regulated Trafficking and Signaling of G Protein–Coupled Receptors
    Mark von Zastrow
    Molecular Pharmacology May 2021, 99 (5) 392-398; DOI: https://doi.org/10.1124/molpharm.120.000178

Articles

  • Open Access
    Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus
    Elham Gholizadeh, Reza Karbalaei, Ali Khaleghian, Mona Salimi, Kambiz Gilany, Rabah Soliymani, Ziaurrehman Tanoli, Hassan Rezadoost, Marc Baumann, Mohieddin Jafari and Jing Tang
    Molecular Pharmacology May 2021, 99 (5) 308-318; DOI: https://doi.org/10.1124/molpharm.120.000210
  • Open Access
    Inhibition of Bitter Taste from Oral Tenofovir Alafenamide
    Erik Schwiebert, Yi Wang, Ranhui Xi, Katarzyna Choma, John Streiff, Linda J. Flammer, Natasha Rivers, Mehmet Hakan Ozdener, Robert F. Margolskee, Carol M. Christensen, Nancy E. Rawson, Peihua Jiang and Paul A. S. Breslin
    Molecular Pharmacology May 2021, 99 (5) 319-327; DOI: https://doi.org/10.1124/molpharm.120.000071
  • You have access
    Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias
    Angela Arsova, Thor C. Møller, Shane D. Hellyer, Line Vedel, Simon R. Foster, Jakob L. Hansen, Hans Bräuner-Osborne and Karen J. Gregory
    Molecular Pharmacology May 2021, 99 (5) 328-341; DOI: https://doi.org/10.1124/molpharm.120.000185
  • The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca<sup>2+</sup> Permeability of GluN1/GluN2A <em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptors
    You have access
    The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca2+ Permeability of GluN1/GluN2A N-Methyl-d-Aspartate Receptors
    Riley E. Perszyk, Zhaoshi Zheng, Tue G. Banke, Jing Zhang, Lingling Xie, Miranda J. McDaniel, Brooke M. Katzman, Stephen C. Pelly, Hongjie Yuan, Dennis C. Liotta and Stephen F. Traynelis
    Molecular Pharmacology May 2021, 99 (5) 399-411; DOI: https://doi.org/10.1124/molpharm.120.000218
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 99 (5)
Molecular Pharmacology
Vol. 99, Issue 5
1 May 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Section on Phosphoproteomic Analysis of G Protein-Coupled Pathways - Axelrod Symposium
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics